Effects of soy foods on ovarian function in premenopausal women
Open accessAbstract
It has been proposed that the high intake of soy foods among Asians may partly explain their lower rates of breast cancer, perhaps by lowering endogenous oestrogen levels, although this has been inadequately studied. Twenty healthy cycling premenopausal women (ten Asians and ten non-Asians) participated in a 7-month soy intervention study which was designed to investigate the effect of supplementation on ovarian function. Asian soy foods (tofu, soymilk, green soybean peas) in the amount of approximately 32 mg of isoflavones per day were added to the women's diets for three menstrual cycles. The women's baseline (two cycles) serum hormone levels were compared to levels during soy intervention (three cycles) and levels after intervention (two cycles). During the entire study period, subjects provided almost daily overnight urine samples and blood specimens during specified days of their menstrual cycles. The day of urinary luteinizing hormone (LH) peak was used as a marker for the day of ovulation. Knowledge of day of ovulation allowed comparison of hormone measurements at baseline to those obtained during intervention and recovery cycles with standardization of day of cycle. Soy intervention was associated with a statistically significant reduction in serum luteal oestradiol level (-9.3%, P < 0.05), but there were no significant changes in follicular phase oestradiol, follicular or luteal phase progesterone, sex hormone-binding globulin or menstrual cycle length. This significant reduction in luteal phase oestradiol was, however, observed only among Asian (-17.4%) but not among non-Asian (-1.2%) participants; urinary excretion of isoflavones was higher among Asians than non-Asians (29.2 vs 17.1 micromol day(-1), P= 0.16) during the intervention period. Thus, supplementation using traditional soy foods reduced serum oestradiol levels among Asian participants in this study. Differences in the type of soy products (i.e. traditional soy foods versus soy protein products), amount of isoflavones, and race/ethnicity of participants may have contributed to the divergent results. Larger soy intervention studies designed specifically to include participants of different race/ethnicities and using both traditional soy foods and soy protein products providing comparable doses of isoflavones are needed to definitively determine the effect of soy on ovarian function.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There were varying results with regard to impact of soy on serum estrogen and progesterone levels.
“There were varying results with regard to impact on serum estrogen and progesterone levels, with two studies showing no significant impact on serum estradiol [120,125], while two studies show significant decreases in estradiol [121,122], and three studies show decreases in progesterone/ luteal phase progesterone [120-122].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [120]
In studies among healthy women, there were no significant changes compared to baseline in endometrial thickness, rates of normal mammogram results, menstrual cycle length, urinary excretion of estrogen, or ratio of urinary estrogen metabolites 2:16 OH-estrone.
“In studies conducted among healthy women, there were no significant changes compared to baseline in endometrial thickness [118]; rates of normal mammogram results [118]; menstrual cycle length [120-122]; or urinary excretion of estrogen [123] or the ratio of urinary estrogen metabolites 2:16 OH-estrone (E1) [123,124].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited by
Sorted by citations
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188 · see citing works
The role of soy and soy isoflavones on women’s fertility and related outcomes: An update
Rizzo, G., Feraco, A., Storz, M. A., & Lombardo, M. (2022) · Journal of Nutritional Science · doi:10.1017/jns.2022.15 · Cited by 34 · see citing works
Patisaul, H., & Whitten, P. (2004) · Endocrine Disruptors · doi:10.1201/9781420038866.ch5 · Cited by 4 · see citing works
- Authors
- Wu, A. H., Stanczyk, F. Z., Hendrich, S., Murphy, P. A., Zhang, C., Wan, P., & Pike, M. C.
- Affiliations
- University of Southern California (US)
- Iowa State University (US)
- Venue
- British Journal of Cancer
- Published
- 2000
- Volume
- 82
- Issue
- 11
- Pages
- 1879-1886
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2363237
- OpenAlex
- W1974321729
- Cited by
- 80
- References
- 0
- Citations by year
- 2022: 1 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 1 · 2014: 1 · 2013: 3 · 2012: 3
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- California Breast Cancer Research Program
- Susan G. Komen
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- soy products, isoflavones, ovarian function, premenopausal women, serum estradiol, urinary luteinizing hormone, ovulation, Asian women, breast cancer risk, sex hormone-binding globulin, dietary supplementation
- MeSH terms
- Adult, Female, Humans, Menstrual Cycle, Middle Aged, Ovary, Glycine max, Premenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review